Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18417462rdf:typepubmed:Citationlld:pubmed
pubmed-article:18417462lifeskim:mentionsumls-concept:C1516985lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0853105lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0123931lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0442711lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18417462lifeskim:mentionsumls-concept:C0701185lld:lifeskim
pubmed-article:18417462pubmed:issue7lld:pubmed
pubmed-article:18417462pubmed:dateCreated2008-6-26lld:pubmed
pubmed-article:18417462pubmed:abstractTextThe aim of this study is to determine efficacy and feasibility of the combination regimen irinotecan and cisplatin in patients with cisplatin advanced penile cancer.lld:pubmed
pubmed-article:18417462pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:languageenglld:pubmed
pubmed-article:18417462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:citationSubsetIMlld:pubmed
pubmed-article:18417462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18417462pubmed:statusMEDLINElld:pubmed
pubmed-article:18417462pubmed:monthJullld:pubmed
pubmed-article:18417462pubmed:issn1569-8041lld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:BodrogiIIlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:LeahyMMlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:VeaFFlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:TheodoreCClld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:KerstJ MJMlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:CollettiPPlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:SkonecznaIIlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:EORTC...lld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:MarréaudSSlld:pubmed
pubmed-article:18417462pubmed:authorpubmed-author:OliverR D TRDlld:pubmed
pubmed-article:18417462pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18417462pubmed:volume19lld:pubmed
pubmed-article:18417462pubmed:ownerNLMlld:pubmed
pubmed-article:18417462pubmed:authorsCompleteYlld:pubmed
pubmed-article:18417462pubmed:pagination1304-7lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:meshHeadingpubmed-meshheading:18417462...lld:pubmed
pubmed-article:18417462pubmed:year2008lld:pubmed
pubmed-article:18417462pubmed:articleTitleA phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).lld:pubmed
pubmed-article:18417462pubmed:affiliationDepartment of Medicine, Institut Gustave Roussy, Villejuif, France. c.theodore@hopital-foch.orglld:pubmed
pubmed-article:18417462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18417462pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:18417462pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:18417462pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18417462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18417462lld:pubmed